<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2024-12-30</publicationDate>
    
        <volume>17</volume>
        <issue>4</issue>

 
    <startPage>2585</startPage>
    <endPage>2592</endPage>

	 
      <doi>10.13005/bpj/3050</doi>
        <publisherRecordId>63092</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Tuberculous Pleurisy: the role of the ADA Enzyme in Diagnosis and Treatment Outcomes</title>

    <authors>
	 


      <author>
       <name>Fazlkhan Abdugapparov</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Lochin Mamatov</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Dauranbek Ongarbayev</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Phthisiology and Pulmonology of the Tashkent medical academy, Republic of Uzbekistan, Tashkent region, Chirchik city, Ibn Sino</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Phthisiology and Pulmonology of the Tashkent medical academy, Republic of Uzbekistan, Tashkent city, Mirabad district, Tallimarjon</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of Phthisiology and Pulmonology of the Tashkent medical academy, Republic of Uzbekistan, Tashkent city, Almazar district, Tansiqbayev</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">Extrapulmonary TB, representing nearly 15% of the global TB burden, is more difficult to diagnose. Tuberculous pleural effusion (TPE), one of the commonest forms of extrapulmonary TB, is a diagnostic challenge with rather poor microbiologic confirmation rates from pleural fluid analysis<sup>2,3</sup>. Even diagnostic tools like CBNAAT and interferon-gamma release assays have shown suboptimal diagnostic accuracy<sup>4,5</sup>. Adenosine deaminase (ADA), an enzyme produced from lymphocytes and involved in purine metabolism, has been extensively studied as a biochemical marker in pleural fluid during investigation for TPE. The test is simple, cheap, rapid, minimally invasive, and can be performed in most laboratories<sup>3</sup>.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol17no4/tuberculous-pleurisy-the-role-of-the-ada-enzyme-in-diagnosis-and-treatment-outcomes/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Adenosine Deaminase</keyword>
      

      
        <keyword> Diagnostic Markers</keyword>
      

      
        <keyword> Pleural Fluid</keyword>
      

      
        <keyword> Tuberculous Pleuritis</keyword>
      

      
        <keyword>  Tuberculosis Treatment Outcomes</keyword>
      
</keywords>
  </record>
</records>